Literature DB >> 24179161

Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention.

Dragan M Matic1, Dejan G Milasinovic, Milika R Asanin, Igor B Mrdovic, Jelena M Marinkovic, Nikola I Kocev, Marija M Marjanovic, Nebojsa M Antonijevic, Vladan D Vukcevic, Lidija Z Savic, Milorad N Zivkovic, Zlatko H Mehmedbegovic, Vladimir M Dedovic, Goran R Stankovic.   

Abstract

OBJECTIVE: To investigate the relationship between inhospital bleeding as defined by Bleeding Academic Research Consortium (BARC) consensus classification and short-term and long-term mortality in unselected patients admitted for primary percutaneous coronary intervention (PCI).
METHODS: We analysed data of all consecutive patients with ST segment elevation myocardial infarction (STEMI) admitted for primary PCI, enrolled in a prospective registry of a high volume centre. The BARC-defined bleeding events were reconstructed from the detailed, prospectively collected clinical data. The primary outcome was mortality at 1 year.
RESULTS: Of the 1808 patients with STEMI admitted for primary PCI, 115 (6.4%) experienced a BARC type ≥2 bleeding. As the BARC bleeding severity worsened, there was a gradient of increasing rates of 1-year death. The 1-year mortality rate increased from 11.5% with BARC 0+1 type to 43.5% with BARC type 3b bleeding. After multivariable adjustment for demographic and clinical characteristics of patients, the independent predictors of 1-year death were BARC type 3a (HR 1.99; 95% CI 1.16 to 3.40, p=0.012) and BARC type 3b bleeding (HR 3.22; 95% CI 1.67 to 6.20, p<0.0001).
CONCLUSIONS: The present study demonstrated that bleeding events defined according to the BARC classification hierarchically correlate with 1-year mortality after admission for primary PCI. The strongest predictor of 1-year mortality is the BARC type 3b bleeding.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24179161     DOI: 10.1136/heartjnl-2013-304564

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  2 in total

1.  The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis.

Authors:  Ying Xue; Zhi-Wei Feng; Xiao-Ye Li; Zi-Heng Hu; Qing Xu; Zi Wang; Jia-Hui Cheng; Hong-Tao Shi; Qi-Bing Wang; Hong-Yi Wu; Xiang-Qun Xie; Qian-Zhou Lv
Journal:  Acta Pharmacol Sin       Date:  2017-09-21       Impact factor: 6.150

2.  Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.

Authors:  Amit P Amin; Tracy Y Wang; Lisa McCoy; Richard G Bach; Mark B Effron; Eric D Peterson; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2016-01-05       Impact factor: 24.094

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.